These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 14508394
1. Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. George DH, Scheithauer BW, Kovacs K, Horvath E, Young WF, Lloyd RV, Meyer FB. Am J Surg Pathol; 2003 Oct; 27(10):1330-6. PubMed ID: 14508394 [Abstract] [Full Text] [Related]
2. Crooke's hyalinization in silent corticotroph adenoma: report of two cases. Roncaroli F, Faustini-Fustini M, Mauri F, Asioli S, Frank G. Endocr Pathol; 2002 Oct; 13(3):245-9. PubMed ID: 12446925 [Abstract] [Full Text] [Related]
3. High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease. Takeshita A, Inoshita N, Taguchi M, Okuda C, Fukuhara N, Oyama K, Ohashi K, Sano T, Takeuchi Y, Yamada S. Eur J Endocrinol; 2009 Oct; 161(4):553-9. PubMed ID: 19589911 [Abstract] [Full Text] [Related]
4. Prevalence and clinical characteristics of Crooke's cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review. Zhu D, Wang Z, Tian T, Wu X, He D, Zhu Y, Liu D, Wang H. Front Endocrinol (Lausanne); 2022 Oct; 13():947085. PubMed ID: 36060980 [Abstract] [Full Text] [Related]
5. Massive Crooke's hyalinization in corticotroph cell adenomas of the human pituitary. A histological, immunocytological, and electron microscopic study of three cases. Felix IA, Horvath E, Kovacs K. Acta Neurochir (Wien); 1981 Oct; 58(3-4):235-43. PubMed ID: 6172012 [Abstract] [Full Text] [Related]
6. Crooke's cell tumors of the pituitary. Di Ieva A, Davidson JM, Syro LV, Rotondo F, Montoya JF, Horvath E, Cusimano MD, Kovacs K. Neurosurgery; 2015 May; 76(5):616-22. PubMed ID: 25635886 [Abstract] [Full Text] [Related]
7. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M, Klibanski A. J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666 [Abstract] [Full Text] [Related]
8. Absence of peritumoral Crooke's change is associated with recurrence in surgically treated Cushing's disease. Hague K, Post KD, Morgello S. Surg Neurol; 2000 Jan; 53(1):77-81. PubMed ID: 10697237 [Abstract] [Full Text] [Related]
9. Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility. Oldfield EH, Vance ML, Louis RG, Pledger CL, Jane JA, Lopes MB. J Clin Endocrinol Metab; 2015 Aug; 100(8):3165-71. PubMed ID: 26147609 [Abstract] [Full Text] [Related]
10. Clinico-pathological study of Cushing's disease with large pituitary adenoma. Ikeda H, Yoshimoto T, Ogawa Y, Mizoi K, Murakami O. Clin Endocrinol (Oxf); 1997 Jun; 46(6):669-79. PubMed ID: 9274697 [Abstract] [Full Text] [Related]
11. Successful reduction of ACTH secretion in a case of intractable Cushing's disease with pituitary Crooke's cell adenoma by combined modality therapy including temozolomide. Tanaka S, Yamamoto M, Morita M, Takeno A, Kanazawa I, Yamaguchi T, Yamada S, Inoshita N, Oki Y, Kurosaki M, Sugimoto T. Endocr J; 2019 Aug 29; 66(8):701-708. PubMed ID: 31130573 [Abstract] [Full Text] [Related]
12. Prognostic indicators in an aggressive pituitary Crooke's cell adenoma. Kovacs K, Diep CC, Horvath E, Cusimano M, Smyth H, Lombardero CC, Scheithauer BW, Lloyd RV. Can J Neurol Sci; 2005 Nov 29; 32(4):540-5. PubMed ID: 16408589 [Abstract] [Full Text] [Related]
13. The role of Crooke's changes in recurrence and remission after gamma knife radiosurgery. Cordeiro D, Xu Z, Nasser M, Lopes B, Vance ML, Sheehan J. J Neurooncol; 2019 Mar 29; 142(1):171-181. PubMed ID: 30607704 [Abstract] [Full Text] [Related]
14. Pituitary corticotroph adenoma with crooke's hyalinization. Franscella S, Favrod-Coune CA, Pizzolato G, Asa SL, Gaillard R, Berney J, Philippe J. Endocr Pathol; 1991 Jun 29; 2(2):111-116. PubMed ID: 32357610 [Abstract] [Full Text] [Related]
15. Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke's cell morphology. Garbicz F, Mehlich D, Rak B, Sajjad E, Maksymowicz M, Paskal W, Zieliński G, Włodarski PK. Pituitary; 2017 Aug 29; 20(4):450-463. PubMed ID: 28432562 [Abstract] [Full Text] [Related]
16. Long-term complete remission of Crooke's corticotropinoma after temozolomide treatment. Kurowska M, Tarach JS, Malicka J, Zieliński G, Maksymowicz M, Denew P. Endokrynol Pol; 2016 Aug 29; 67(5):526-533. PubMed ID: 27828691 [Abstract] [Full Text] [Related]
17. Clinicopathologic correlations of silent corticotroph adenomas of the pituitary: report of four cases and literature review. Sahli R, Christ ER, Seiler R, Kappeler A, Vajtai I. Pathol Res Pract; 2006 Aug 29; 202(6):457-64. PubMed ID: 16497445 [Abstract] [Full Text] [Related]
18. Corticotroph pituitary carcinoma: case report and literature review. Holthouse DJ, Robbins PD, Kahler R, Knuckey N, Pullan P. Endocr Pathol; 2001 Aug 29; 12(3):329-41. PubMed ID: 11740054 [Abstract] [Full Text] [Related]
19. Cytokeratin CK20 is a sensitive marker for Crooke's cells and the early cytoskeletal changes associated with hypercortisolism within pituitary corticotrophs. Eschbacher JM, Coons SW. Endocr Pathol; 2006 Aug 29; 17(4):365-76. PubMed ID: 17525485 [Abstract] [Full Text] [Related]
20. Aggressive Pituitary Tumor with Crooke's Cells and Invasion of the Posterior Fossa. Cortez GM, Monteiro A, Agnoletto G, Bit-Ivan EN, Sauvageau E, Hanel RA. World Neurosurg; 2020 Jun 29; 138():530-534.e1. PubMed ID: 32145418 [Abstract] [Full Text] [Related] Page: [Next] [New Search]